Where does Morpheus AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Morpheus AG ranks #36,551 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Morpheus AG hold?

Morpheus AG holds 7 US utility patents granted between 2016 and 2024, spanning 7 technology areas.

What is Morpheus AG's Innovation Score?

Morpheus AG has an Innovation Score of 29.6 out of 100 (31st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Morpheus AG focus on?

Morpheus AG's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 4 patents, ranking #3,645 of 7,127 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Morpheus AG's patent grant rate increasing or decreasing?

Morpheus AG's recent grant velocity is +150% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Morpheus AG's patents?

Morpheus AG's patents average 14.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Morpheus AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Morpheus AG

USPTO PatentsView assignee record - 7 granted patents across 7 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Morpheus ranks #36,551 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 7 technology areas.

#36,551
of 49,997 US assignees by volume: 31st percentile
by Innovation Score (29.6/100): 14.4
avg claims per patent: +150%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R36551 · Foreign Corporation #36,551 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #36,551/49,997
PHOTO-FINISH Mono Slab EZ Form
CPC-NARROW A61B · 7 areas
INNOV-THIN 29.6/100
CLAIMS-RICH 14.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +150% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Mono Slab EZ Form LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Morpheus’s 29.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (24%) Velocity 4.4 pts (15%) Breadth 9.4 pts (32%) Claim depth 8.7 pts (29%)

Qualcomm Incorporated · highest

85
Morpheus · this assignee

30
3D Lighting… · lowest

7

What this shows Morpheus's Innovation Score is 29.6/100 (31st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Morpheus?

Each dot is one of Morpheus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Morpheus’s own 14.4 claims/patent is at or below the 15.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Morpheus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Morpheus's grants concentrate

Morpheus AG is a focused PatentsView assignee: 7 CPC subclasses with 57.1% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2021 (3 grants) versus a trough of 1 in 2016. By volume, Morpheus sits between Mono Slab EZ Form LLC and MSD International GMBH.

Morpheus's three-year grant acceleration

Morpheus AG shows 2 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Mono Slab EZ Form

7
Monogram Aerospac…

7
Montage (Shanghai)

7
Montres Tudor

7
Mosaic Biosciences

7
Moteck Electric

7
Mozido

7
MSD International

7
Morpheus ◀

7

What this shows Morpheus holds 7 patents at rank #36,420, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Morpheus

By rank, the assignees closest to #36,420 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Morpheus's primary technology class.

Morpheus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 31st percentile higher than 31% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Morpheus AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	14.3%
2017	1	14.3%
2021	3	42.9%
2022	1	14.3%
2024	1	14.3%

Which technologies does Morpheus AG patent most?

A61B - DIAGNOSIS; SURGERY; Identification 4

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

G06T - Image Data Processing OR Generation, IN General 2

G06V - Image OR Video Recognition OR Understanding 1

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 1

G08B - Signalling OR Calling SYSTEMS; Order TELEGRAPHS; Alarm Systems 1

G16Z - Information AND Communication Technology [ICT] Specially Adapted FOR Specific Application Fields, NOT Otherwise Provided FOR 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Morpheus AG's patent record in context - here's where to go next.

Morpheus AG's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 57.1% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #36,551 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Morpheus AG against Mono Slab EZ Form LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.